[Skip to Content]
[Skip to Content Landing]
Viewpoint
July 2017

Relationship Between the American Academy of Pediatrics and Infant Formula Companies

Author Affiliations
  • 1Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
  • 2The Herman and Walter Children's Hospital at Sinai, Sinai Hospital, Baltimore, Maryland
JAMA Pediatr. 2017;171(7):613-614. doi:10.1001/jamapediatrics.2017.1257

In 2005, the board of directors of the American Academy of Pediatrics (AAP) adopted a policy supporting relationships with companies that, “through their products, activities, and/or their philosophy, enhance the quality of life for children and their families and are aligned with the AAP’s values and mission” (https://www.aap.org/en-us/about-the-aap/aap-leadership/Documents/20-IndustryRelations.pdf). In doing so, the organization chose to apply a higher standard than simply asking whether corporate funding can be put to good use. Under this policy, the AAP should reassess its engagement with companies that sell infant formula.

×